Effects of selective dopamine D2-receptor agonists on the release of cholecystokinin-like immunoreactivity from rat neostriatum.
It was investigated whether or not the release of cholecystokinin-like immunoreactivity from slices of rat caudatoputamen could be modulated via dopamine D2-receptors. The release of immunoreactivity was stimulated by high concentrations of K+ (35 to 55 mM). The effects of two D2-selective dopaminergic agonists, RU 24926 and LY 141865, were tested on the K+-induced release. Both agents enhanced the release of immunoreactivity in a concentration-dependent manner. The effect of RU 24926 was blocked by (-)-sulpiride and domperidone, two selective D2-antagonists. It is concluded that stimulation of dopamine receptors of the D2-subtype enhances the release of cholecystokinin-like immunoreactivity from nerve endings in rat neostriatum.